Discriminative stimulus properties of 1.25 mg/kg clozapine in rats

Mediation by serotonin 5-HT2 and dopamine D4 receptors

Adam J. Prus, Laura E. Wise, Alan Pehrson, Scott D. Philibin, Benny Bang-Andersen, Jørn Arnt, Joseph H. Porter

Research output: Contribution to journalArticleResearchpeer-review

4 Citations (Scopus)

Abstract

The atypical antipsychotic drug clozapine remains one of most effective treatments for schizophrenia, given a lack of extrapyramidal side effects, improvements in negative symptoms, cognitive impairment, and in symptoms in treatment-resistant schizophrenia. The adverse effects of clozapine, including agranulocytosis, make finding a safe clozapine-like a drug a goal for drug developers. The drug discrimination paradigm is a model of interoceptive stimulus that has been used in an effort to screen experimental drugs for clozapine-like atypical antipsychotic effects. The present study was conducted to elucidate the receptor-mediated stimulus properties that form this clozapine discriminative cue by testing selective receptor ligands in rats trained to discriminate a 1.25 mg/kg dose of clozapine from vehicle in a two choice drug discrimination task. Full substitution occurred with the 5-HT2A inverse agonist M100907 and the two preferential D4/5-HT21 receptor antagonists Lu 37-114 ((S)-1-(3-(2-(4-(1H-indol-5-yl)piperazin-1-yl)ethyl)indolin-1-yl)ethan-1-one) and Lu 37-254 (1-(3-(4-(1H-indol-5-yl)piperazin-1-yl)propyl)-3,4-dihydroquinolin-2(1H)-one). Partial substitution occurred with the D4 receptor antagonist Lu 38-012 and the α1 adrenoceptor antagonist prazosin. Drugs selective for 5-HT2C, 5-HT6 muscarinic, histamine H1, and benzodiazepine receptors did not substitute for clozapine. The present findings suggest that 5-HT2A inverse agonism and D4 receptor antagonism mediate the discriminative stimulus properties of 1.25 mg/kg clozapine in rats, and further confirm that clozapine produces a complex compound discriminative stimulus.

Original languageEnglish
Pages (from-to)298-305
Number of pages8
JournalBrain Research
Volume1648
DOIs
StatePublished - 1 Oct 2016

Fingerprint

Dopamine D4 Receptors
Clozapine
Serotonin
Pharmaceutical Preparations
Antipsychotic Agents
Schizophrenia
Serotonin 5-HT2 Receptor Agonists
Histamine H1 Receptors
Agranulocytosis
Prazosin
GABA-A Receptors
Adrenergic Receptors
Cholinergic Agents
Cues
Ligands

Keywords

  • 5-HT2 receptor
  • Antipsychotic
  • D4 receptor
  • Dopamine
  • Drug discrimination
  • Serotonin

Cite this

Prus, Adam J. ; Wise, Laura E. ; Pehrson, Alan ; Philibin, Scott D. ; Bang-Andersen, Benny ; Arnt, Jørn ; Porter, Joseph H. / Discriminative stimulus properties of 1.25 mg/kg clozapine in rats : Mediation by serotonin 5-HT2 and dopamine D4 receptors. In: Brain Research. 2016 ; Vol. 1648. pp. 298-305.
@article{05ec685d1b774a838b35e443353ed18b,
title = "Discriminative stimulus properties of 1.25 mg/kg clozapine in rats: Mediation by serotonin 5-HT2 and dopamine D4 receptors",
abstract = "The atypical antipsychotic drug clozapine remains one of most effective treatments for schizophrenia, given a lack of extrapyramidal side effects, improvements in negative symptoms, cognitive impairment, and in symptoms in treatment-resistant schizophrenia. The adverse effects of clozapine, including agranulocytosis, make finding a safe clozapine-like a drug a goal for drug developers. The drug discrimination paradigm is a model of interoceptive stimulus that has been used in an effort to screen experimental drugs for clozapine-like atypical antipsychotic effects. The present study was conducted to elucidate the receptor-mediated stimulus properties that form this clozapine discriminative cue by testing selective receptor ligands in rats trained to discriminate a 1.25 mg/kg dose of clozapine from vehicle in a two choice drug discrimination task. Full substitution occurred with the 5-HT2A inverse agonist M100907 and the two preferential D4/5-HT2/α1 receptor antagonists Lu 37-114 ((S)-1-(3-(2-(4-(1H-indol-5-yl)piperazin-1-yl)ethyl)indolin-1-yl)ethan-1-one) and Lu 37-254 (1-(3-(4-(1H-indol-5-yl)piperazin-1-yl)propyl)-3,4-dihydroquinolin-2(1H)-one). Partial substitution occurred with the D4 receptor antagonist Lu 38-012 and the α1 adrenoceptor antagonist prazosin. Drugs selective for 5-HT2C, 5-HT6 muscarinic, histamine H1, and benzodiazepine receptors did not substitute for clozapine. The present findings suggest that 5-HT2A inverse agonism and D4 receptor antagonism mediate the discriminative stimulus properties of 1.25 mg/kg clozapine in rats, and further confirm that clozapine produces a complex compound discriminative stimulus.",
keywords = "5-HT2 receptor, Antipsychotic, D4 receptor, Dopamine, Drug discrimination, Serotonin",
author = "Prus, {Adam J.} and Wise, {Laura E.} and Alan Pehrson and Philibin, {Scott D.} and Benny Bang-Andersen and J{\o}rn Arnt and Porter, {Joseph H.}",
year = "2016",
month = "10",
day = "1",
doi = "10.1016/j.brainres.2016.08.004",
language = "English",
volume = "1648",
pages = "298--305",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",

}

Discriminative stimulus properties of 1.25 mg/kg clozapine in rats : Mediation by serotonin 5-HT2 and dopamine D4 receptors. / Prus, Adam J.; Wise, Laura E.; Pehrson, Alan; Philibin, Scott D.; Bang-Andersen, Benny; Arnt, Jørn; Porter, Joseph H.

In: Brain Research, Vol. 1648, 01.10.2016, p. 298-305.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Discriminative stimulus properties of 1.25 mg/kg clozapine in rats

T2 - Mediation by serotonin 5-HT2 and dopamine D4 receptors

AU - Prus, Adam J.

AU - Wise, Laura E.

AU - Pehrson, Alan

AU - Philibin, Scott D.

AU - Bang-Andersen, Benny

AU - Arnt, Jørn

AU - Porter, Joseph H.

PY - 2016/10/1

Y1 - 2016/10/1

N2 - The atypical antipsychotic drug clozapine remains one of most effective treatments for schizophrenia, given a lack of extrapyramidal side effects, improvements in negative symptoms, cognitive impairment, and in symptoms in treatment-resistant schizophrenia. The adverse effects of clozapine, including agranulocytosis, make finding a safe clozapine-like a drug a goal for drug developers. The drug discrimination paradigm is a model of interoceptive stimulus that has been used in an effort to screen experimental drugs for clozapine-like atypical antipsychotic effects. The present study was conducted to elucidate the receptor-mediated stimulus properties that form this clozapine discriminative cue by testing selective receptor ligands in rats trained to discriminate a 1.25 mg/kg dose of clozapine from vehicle in a two choice drug discrimination task. Full substitution occurred with the 5-HT2A inverse agonist M100907 and the two preferential D4/5-HT2/α1 receptor antagonists Lu 37-114 ((S)-1-(3-(2-(4-(1H-indol-5-yl)piperazin-1-yl)ethyl)indolin-1-yl)ethan-1-one) and Lu 37-254 (1-(3-(4-(1H-indol-5-yl)piperazin-1-yl)propyl)-3,4-dihydroquinolin-2(1H)-one). Partial substitution occurred with the D4 receptor antagonist Lu 38-012 and the α1 adrenoceptor antagonist prazosin. Drugs selective for 5-HT2C, 5-HT6 muscarinic, histamine H1, and benzodiazepine receptors did not substitute for clozapine. The present findings suggest that 5-HT2A inverse agonism and D4 receptor antagonism mediate the discriminative stimulus properties of 1.25 mg/kg clozapine in rats, and further confirm that clozapine produces a complex compound discriminative stimulus.

AB - The atypical antipsychotic drug clozapine remains one of most effective treatments for schizophrenia, given a lack of extrapyramidal side effects, improvements in negative symptoms, cognitive impairment, and in symptoms in treatment-resistant schizophrenia. The adverse effects of clozapine, including agranulocytosis, make finding a safe clozapine-like a drug a goal for drug developers. The drug discrimination paradigm is a model of interoceptive stimulus that has been used in an effort to screen experimental drugs for clozapine-like atypical antipsychotic effects. The present study was conducted to elucidate the receptor-mediated stimulus properties that form this clozapine discriminative cue by testing selective receptor ligands in rats trained to discriminate a 1.25 mg/kg dose of clozapine from vehicle in a two choice drug discrimination task. Full substitution occurred with the 5-HT2A inverse agonist M100907 and the two preferential D4/5-HT2/α1 receptor antagonists Lu 37-114 ((S)-1-(3-(2-(4-(1H-indol-5-yl)piperazin-1-yl)ethyl)indolin-1-yl)ethan-1-one) and Lu 37-254 (1-(3-(4-(1H-indol-5-yl)piperazin-1-yl)propyl)-3,4-dihydroquinolin-2(1H)-one). Partial substitution occurred with the D4 receptor antagonist Lu 38-012 and the α1 adrenoceptor antagonist prazosin. Drugs selective for 5-HT2C, 5-HT6 muscarinic, histamine H1, and benzodiazepine receptors did not substitute for clozapine. The present findings suggest that 5-HT2A inverse agonism and D4 receptor antagonism mediate the discriminative stimulus properties of 1.25 mg/kg clozapine in rats, and further confirm that clozapine produces a complex compound discriminative stimulus.

KW - 5-HT2 receptor

KW - Antipsychotic

KW - D4 receptor

KW - Dopamine

KW - Drug discrimination

KW - Serotonin

UR - http://www.scopus.com/inward/record.url?scp=84981484911&partnerID=8YFLogxK

U2 - 10.1016/j.brainres.2016.08.004

DO - 10.1016/j.brainres.2016.08.004

M3 - Article

VL - 1648

SP - 298

EP - 305

JO - Brain Research

JF - Brain Research

SN - 0006-8993

ER -